retatrutide clinical trial germany just delivered the first top-line Phase 3 results for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 retatrutide clinical trial germany I

the human trials in this family used full-length thymosin beta-4 as an eye drop for dry eye

A recent study of BBB penetration by GLP-1 class drugs on the market and dual agonists that have modifications to cross the BBB at an enhanced rate confirmed this (Salameh et al., 2020)

[PUBMED Abstract] Liu L, Dilworth D, Gao L, et al.: Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma

causal attribution to specific receptor pathways requires further human data

After the approval of Ibrance, there were certain companies that attempted to launch their generics trying to claim false statements against the approval of Pfizers patent for Ibrance

But with that influx comes headaches for the patients seeking the drugs, and the physicians who prescribe them